European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis

European Respiratory Journal

Volumn 35, Issue 1, 2010, Pages 14-26

  Johnson, S R ^a   Cordier, J F ^b   Lazor, R ^b,c   Cottin, V ^b   Costabel, U ^d   Harari, S ^e   Reynaud Gaubert, M ^f   Boehler, A ^g   Brauner, M ^h   Popper, H ⁱ   Bonetti, F ^j   Kingswood, C ^k   Albera, C ^l   Bissler, J ^l   Bouros, D ^l   Corris, P ^l   Donnelly, S ^l   Durand, C ^l   Egan, J ^l   Grutters, J C ^l   Hodgson, U ^l   Hollis, G ^l   Korzeniewska Kosela, M ^l   Kus, J ^l   Lacronique, J ^l   Lammers, J W ^l   McCormack, F ^l   Mendes, A C ^l   Moss, J ^l   Naalsund, A ^l   Pohl, W ^l   Radzikowska, E ^l   Robalo Cordeiro, C ^l   Rouviere O ^l   Ryu, J ^l   Schiavina, M ^l   Tattersfield, A E ^l   Travis, W ^l   Tukiainen, P ^l   Urban, T ^l   Valeyre, D ^l   Verleden, G M ^l   more..

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b UNIVERSITÉ LYON 1   (France)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e San Giuseppe Hospital   (Italy)

^f HÔPITAL SAINTE MARGUERITE   (France)

^g UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^h AVICENNE HOSPITAL   (France)

ⁱ UNIVERSITY OF GRAZ   (Austria)

^j UNIVERSITY OF VERONA   (Italy)

^k ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^l NONE

more..

Author keywords

Angiomyolipoma; Chylous effusions; Cystic lung disease; Lymphangioleiomyomatosis; Pneumothorax; Tuberous sclerosis

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; ESTRADIOL; GONADORELIN AGONIST; IMMUNOSUPPRESSIVE AGENT; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; RAPAMYCIN; TAMOXIFEN; TRIACYLGLYCEROL; TUBERIN;

AIRWAY OBSTRUCTION; ANGIOMYOLIPOMA; ARTERIAL GAS; ARTIFICIAL EMBOLISM; AVIATION; BONE DENSITY; CANCER RISK; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHYLOTHORAX; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DYSPNEA; FOLLOW UP; FORCED EXPIRATORY VOLUME; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HIGH RISK POPULATION; HORMONE SUBSTITUTION; HUMAN; HYPOXEMIA; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA; LIPID DIET; LUNG BIOPSY; LUNG FUNCTION; LUNG FUNCTION TEST; LUNG TRANSPLANTATION; LYMPHANGIOLEIOMYOMATOSIS; MENINGIOMA; NEPHRON SPARING SURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOPOROSIS; OVARIECTOMY; OXYGEN THERAPY; PATHOLOGY; PHYSICAL EXAMINATION; PLEURECTOMY; PLEURODESIS; PNEUMOTHORAX; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; PULMONARY REHABILITATION; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SPIROMETRY; SPONTANEOUS PNEUMOTHORAX; TOTAL PARENTERAL NUTRITION; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; ULTRASOUND; VACCINATION; WEIGHT BEARING;

EID: 75149168979     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00076209     Document Type: Review

References (112)

1. Johnson S. Lymphangioleiomyomatosis: clinical features, management and basic mechanisms. Thorax 1999; 54: 254-264.
2. Franz DN, Brody A, Meyer C, et al. Mutational and radiographic analysis of pulmonary disease consistent with lymphangioleiomyomatosis and micronodular pneumocyte hyperplasia in women with tuberous sclerosis. Am J Respir Crit Care Med 2001; 164: 661-668.
3. Urban T, Lazor R, Lacronique J, et al. Pulmonary lymphangioleiomyomatosis. A study of 69 patients. Groupe d'Etudes et de Recherche sur les Maladies "Orphelines" Pulmonaires (GERM"O"P). Medicine (Baltimore) 1999; 78: 321-337.
4. Johnson SR, Tattersfield AE. Decline in lung function in lymphangioleiomyomatosis: relation to menopause and progesterone treatment. Am J Respir Crit Care Med 1999; 160: 628-633.
5. Aubry MC, Myers JL, Ryu JH, et al. Pulmonary lymphangioleiomyomatosis in a man. AmJ Respir Crit Care Med 2000; 162: 749-752.
6. Schiavina M, Di Scioscio V, Contini P, et al. Pulmonary lymphangioleiomyomatosis in a karyotypically normal man without tuberous sclerosis complex. Am J Respir Crit Care Med 2007; 176: 96-98.
7. Avila NA, Kelly JA, Chu SC, et al. Lymphangioleiomyomatosis: abdominopelvic CT and US findings. Radiology 2000; 216: 147-153.
8. Chu SC, Horiba K, Usuki J, et al. Comprehensive evaluation of 35 patients with lymphangioleiomyomatosis. Chest 1999; 115: 1041-1052.
9. Moss J, DeCastro R, Patronas NJ, et al. Meningiomas in lymphangioleiomyomatosis. JAMA 2001; 286: 1879-1881.
10. Johnson SR, Tattersfield AE. Clinical experience of lymphangioleiomyomatosis in the UK. Thorax 2000; 55: 1052-1057.
11. Ryu JH, Doerr CH, Fisher SD, et al. Chylothorax in lymphangioleiomyomatosis. Chest 2003; 123: 623-627.
12. Goncharova EA, Goncharov DA, Eszterhas A, et al. Tuberin regulates p70 S6 kinase activation and ribosomal protein S6 phosphorylation. A role for the TSC2 tumor suppressor gene in pulmonary lymphangioleiomyomatosis (LAM). J Biol Chem 2002; 277: 30958-30967.
13. Kenerson H, Folpe AL, Takayama TK, et al. Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms. Human Pathology 2007; 38: 1361-1371.
14. Bissler JJ, McCormack FX, Young LR, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008; 358: 140-151.
15. Davies DM, Johnson SR, Tattersfield AE, et al. Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis. N Engl J Med 2008; 358: 200-203.
16. McCrory DC, Lewis SZ. Methodology and grading for pulmonary hypertension evidence review and guideline development. Chest 2004; 126, Suppl. 1, 11S-13S.
17. Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: An American College of Chest Physicians Delphi Consensus Statement. Chest 2001; 119: 590-602.
18. Ryu JH, Moss J, Beck GJ, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006; 173: 105-111.
19. Johnson SR, Whale CI, Hubbard RB, et al. Survival and disease progression in UK patients with lymphangioleiomyomatosis. Thorax 2004; 59: 800-803.
20. Kitaichi M, Nishimura K, Itoh H, et al. Pulmonary lymphangioleiomyomatosis: a report of 46 patients including a clinicopathologic study of prognostic factors. Am J Respir Crit Care Med 1995; 151: 527-533.
21. Taveira-DaSilva AM, Stylianou MP, Hedin CJ, et al. Decline in lung function in patients with lymphangioleiomyomatosis treated with or without progesterone. Chest 2004; 126: 1867-1874.
22. Carrington CB, Cugell DW, Gaensler EA, et al. Lymphangioleiomyomatosis. Physiologic-pathologic-radiologic correlations. Am Rev Respir Dis 1977; 116: 977-995.
23. Matsui K, Beasley MB, Nelson WK, et al. Prognostic significance of pulmonary lymphangioleiomyomatosis histologic score. Am J Surg Pathol 2001; 25: 479-484.
24. Corrin B, Liebow A, Friedman P. Pulmonary lymphangiomyomatosis. A review. Am J Pathol 1975; 79: 348-382.
25. Bonetti F, Chiodera PL, Pea M, et al. Transbronchial biopsy in lymphangiomyomatosis of the lung. HMB45 for diagnosis. Am J Surg Pathol 1993; 17: 1092-1102.
26. Matsui K, Takeda K, Yu ZX, et al. Downregulation of estrogen and progesterone receptors in the abnormal smooth muscle cells in pulmonary lymphangioleiomyomatosis following therapy. An immunohistochemical study. Am J Respir Crit Care Med 2000; 161: 1002-1009.
27. Glassberg MK, Elliot SJ, Fritz J, et al. Activation of the estrogen receptor contributes to the progression of pulmonary lymphangioleiomyomatosis via MMP-induced cell invasiveness. J Clin Endocrinol Metab 2008; 93: 1625-1633.
28. Zompatori M, Poletti V, Battista G, et al. Diffuse cystic lung disease in the adult patient. Radiol Med (Torino) 2000; 99: 12-21.
29. Steagall WK, Glasgow CG, Hathaway OM, et al. Genetic and morphologic determinants of pneumothorax in lymphangioleiomyomatosis. Am J Physiol Lung Cell Mol Physiol 2007; 293: L800-L808.
30. Avila NA, Chen CC, Chu SC, et al. Pulmonary lymphangioleiomyomatosis: correlation of ventilation-perfusion scintigraphy, chest radiography, and CT with pulmonary function tests. Radiology 2000; 214: 441-446.
31. Lenoir S, Grenier P, Brauner MW, et al. Pulmonary lymphangiomyomatosis and tuberous sclerosis: comparison of radiographic and thin-section CT findings. Radiology 1990; 175: 329-334.
32. Muller NL, Chiles C, Kullnig P. Pulmonary lymphangiomyomatosis: correlation of CT with radiographic and functional findings. Radiology 1990; 175: 335-339.
33. Abbott GF, Rosado-de-Christenson ML, Frazier AA, et al. From the archives of the AFIP: lymphangioleiomyomatosis: radiologicpathologic correlation. Radiographics 2005; 25: 803-828.
34. Helenon O, Merran S, Paraf F, et al. Unusual fat-containing tumors of the kidney: a diagnostic dilemma. Radiographics 1997; 17: 129-144.
35. Roach ES, Sparagana SP. Diagnosis of tuberous sclerosis complex. J Child Neurol 2004; 19: 643-649.
36. Taveira-DaSilva AM, Hedin C, Stylianou MP, et al. Reversible airflow obstruction, proliferation of abnormal smooth muscle cells, and impairment of gas exchange as predictors of outcome in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2001; 164: 1072-1076.
37. Taylor JR, Ryu J, Colby TV, et al. Lymphangioleiomyomatosis. Clinical course in 32 patients. N Engl J Med 1990; 323: 1254-1260.
38. Boehler A, Speich R, Russi EW, et al. Lung transplantation for lymphangioleiomyomatosis. N Engl J Med 1996; 335: 1275-1280.
39. Taveira-DaSilva AM, Stylianou MP, Hedin CJ, et al. Maximal oxygen uptake and severity of disease in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2003; 168: 1427-1431.
40. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166: 111-117.
41. Costello LC, Hartman TE, Ryu JH. High frequency of pulmonary lymphangioleiomyomatosis in women with tuberous sclerosis complex. Mayo Clin Proc 2000; 75: 591-594.
42. Moss J, Avila NA, Barnes PM, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001; 164: 669-671.
43. Castro M, Shepherd CW, Gomez MR, et al. Pulmonary tuberous sclerosis. Chest 1995; 107: 189-195.
44. Kim NR, Chung MP, Park CK, et al. Pulmonary lymphangioleiomyomatosis and multiple hepatic angiomyolipomas in a man. Pathology International 2003; 53: 231-235.
45. Casper KA, Donnelly LF, Chen B, et al. Tuberous sclerosis complex: renal imaging findings. Radiology 2002; 225: 451-456.
46. Ewalt DH, Sheffield E, Sparagana SP, et al. Renal lesion growth in children with tuberous sclerosis complex. J Urol 1998; 160: 141-145.
47. Weiner DM, Ewalt DH, Roach ES, et al. The tuberous sclerosis complex: a comprehensive review. J Am Coll Surg 1998; 187: 548-561.
48. L'Hostis H, Deminiere C, Ferriere JM, et al. Renal angiomyolipoma: a clinicopathologic, immunohistochemical, and follow-up study of 46 cases. Am J Surg Pathol 1999; 23: 1011-1020.
49. Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002; 168: 1315-1325.
50. Steiner MS, Goldman SM, Fishman EK, et al. The natural history of renal angiomyolipoma. J Urol 1993; 150: 1782-1786.
51. Kennelly MJ, Grossman HB, Cho KJ. Outcome analysis of 42 cases of renal angiomyolipoma. J Urol 1994; 152: 1988-1991.
52. Dickinson M, Ruckle H, Beaghler M, et al. Renal angiomyolipoma: optimal treatment based on size and symptoms. Clin Nephrol 1998; 49: 281-286.
53. CO predicts rapid FEV1 decline in pulmonary lymphangioleiomyomatosis. Respir Med 2004; 98: 536-541.
54. Cohen MM, Pollock-BarZiv S, Johnson SR. Emerging clinical picture of lymphangioleiomyomatosis. Thorax 2005; 60: 875-879.
55. Almoosa KF, Ryu JH, Mendez J, et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest 2006; 129: 1274-1281.
56. Fujimoto M, Ohara N, Sasaki H, et al. Pregnancy complicated with pulmonary lymphangioleiomyomatosis: case report. Clin Exp Obstet Gynecol 2005; 32: 199-200.
57. Brunelli A, Catalini G, Fianchini A. Pregnancy exacerbating unsuspected mediastinal lymphangioleiomyomatosis and chylothorax. Int J Gynaecol Obstet 1996; 52: 289-290.
58. McLoughlin L, Thomas G, Hasan K. Pregnancy and lymphangioleiomyomatosis: anaesthetic management. Int J Obstet Anesth 2003; 12: 40-44.
59. Yockey CC, Riepe RE, Ryan K. Pulmonary lymphangioleiomyomatosis complicated by pregnancy. Kans Med 1986; 87, 277-278: 293.
60. Warren SE, Lee D, Martin V, et al. Pulmonary lymphangiomyomatosis causing bilateral pneumothorax during pregnancy. Ann Thorac Surg 1000; 55: 998-1000.
61. Cohen MM, Freyer AM, Johnson SR. Pregnancy experiences among women with lymphangioleiomyomatosis. Respir Med 2009; 103: 766-772.
62. Raft J, Lalot JM, Meistelman C, et al. [Renal angiomyolipoma rupture during pregnancy.] Gynecol Obstet Fertil 2006; 34: 917-919.
63. Storm DW, Mowad JJ. Conservative management of a bleeding renal angiomyolipoma in pregnancy. Obstet Gynecol 2006; 107: 490-492.
64. Morales JP, Georganas M, Khan MS, et al. Embolization of a bleeding renal angiomyolipoma in pregnancy: case report and review. Cardiovasc Intervent Radiol 2005; 28: 265-268.
65. Mascarenhas R, McLaughlin P. Haemorrhage from angiomyolipoma of kidney during pregnancy - a diagnostic dilemma. Ir Med J 2001; 94: 83-84.
66. Yano S. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous oestrogen used for infertility treatment. Thorax 2002; 57: 1085-1086.
67. Shen A, Iseman MD, Waldron JA, et al. Exacerbation of pulmonary lymphangioleiomyomatosis by exogenous estrogens. Chest 1987; 91: 782-785.
68. Wilson AM, Slack HL, Soosay SA, et al. Lymphangioleiomyomatosis. A series of three case reports illustrating the link with high oestrogen states. Scott Med J 2001; 46: 150-152.
69. Oberstein EM, Fleming LE, Gomez-Marin O, et al. Pulmonary lymphangioleiomyomatosis (LAM): examining oral contraceptive pills and the onset of disease. J Women's Health 2003; 12: 81-85.
70. Pollock-BarZiv S, Cohen MM, Downey GP, et al. Air travel in women with lymphangioleiomyomatosis. Thorax 2007; 62: 176-180.
71. Rehabilitation BTSSoCs-coP. BTS statement on pulmonary rehabilitation. Thorax 2001; 56: 827-834.
72. Managing stable COPD. Thorax 2004; 59: Suppl. 1, i39-i130.
73. Taveira-DaSilva AM, Stylianou MP, Hedin CJ, et al. Bone mineral density in lymphangioleiomyomatosis. Am J Respir Crit Care Med 2005; 171: 61-67.
74. Adamson D, Heinrichs WL, Raybin DM, et al. Successful treatment of pulmonary lymphangiomyomatosis with oophorectomy and progesterone. Am Rev Respir Dis 1985; 132: 916-921.
75. Anker N, Francis D, Viskum K. [2 cases of lymphangioleiomyomatosis treated by hormonal manipulation.] Ugeskr Laeger 1993; 155: 2354-2356.
76. Banner AS, Carrington CB, Emory WB, et al. Efficacy of oophorectomy in lymphangioleiomyomatosis and benign metastasizing leiomyoma. N Engl J Med 1981; 305: 204-209.
77. Itoi K, Kuwabara M, Okubo K, et al. [A case of pulmonary lymphangiomyomatosis treated with bilateral oophorectomy and methyl-progesterone-acetate.] Nihon Kyobu Shikkan Gakkai Zasshi 1993; 31: 1146-1150.
78. Kanbe A, Hajiro K, Adachi Y, et al. Lymphangiomyomatosis associated with chylous ascites and high serum CA-125 levels: a case report. Jpn J Med 1987; 26: 237-242.
79. Brock ET, Votto JJ. Lymphangioleiomyomatosis: treatment with hormonal manipulation. N Y State J Med 1986; 86: 533-536.
80. Klein M, Krieger O, Ruckser R, et al. Treatment of lymphangioleiomyomatosis by ovariectomy, interferon alpha 2b and tamoxifen-a case report. Arch Gynecol Obstet 1992; 252: 99-102.
81. Svendsen TL, Viskum K, Hansborg N, et al. Pulmonary lymphangioleiomyomatosis: a case of progesterone receptor positive lymphangioleiomyomatosis treated with medroxyprogesterone, oophorectomy and tamoxifen. Br J Dis Chest 1984; 78: 264-271.
82. Tomasian A, Greenberg MS, Rumerman H. Tamoxifen for lymphangioleiomyomatosis. N Engl J Med 1982; 306: 745-746.
83. de la Fuente J, Paramo C, Roman F, et al. Lymphangioleiomyomatosis: unsuccessful treatment with luteinizing-hormone- releasing hormone analogues. Eur J Med 1993; 2: 377-378.
84. Desurmont S, Bauters C, Copin MC, et al. [Treatment of pulmonary lymphangioleiomyomatosis using a GnRH agonist.] Rev Mal Respir 1996; 13: 300-304.
85. Rossi GA, Balbi B, Oddera S, et al. Response to treatment with an analog of the luteinizing-hormone-releasing hormone in a patient with pulmonary lymphangioleiomyomatosis. Am Rev Respir Dis 1991; 143: 174-176.
86. Harari S, Cassandro R, Chiodini J, et al. Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis. Chest 2008; 133: 448-454.
87. Detterbeck FC, Egan TM, Mill MR. Lung transplantation after previous thoracic surgical procedures. Ann Thorac Surg 1995; 60: 139-143.
88. Pechet TT, Meyers BF, Guthrie TJ, et al. Lung transplantation for lymphangioleiomyomatosis. J Heart Lung Transplant 2004; 23: 301-308.
89. Morimoto N, Hirasaki S, Kamei T, et al. Pulmonary lymphangiomyomatosis (LAM) developing chylothorax. Intern Med 2000; 39: 738-741.
90. Christodoulou M, Ris H-B, Pezzetta E. Video-assisted right supradiaphragmatic thoracic duct ligation for non-traumatic recurrent chylothorax. Eur J Cardiothorac Surg 2006; 29: 810-814.
91. Avila NA, Dwyer AJ, Rabel A, et al. CT of pleural abnormalities in lymphangioleiomyomatosis and comparison of pleural findings after different types of pleurodesis. AJR Am J Roentgenol 2006; 186: 1007-1012.
92. Druelle S, Aubry P, Levi-Valensi P. [Pulmonary lymphangiomyomatosis: a 3-year follow-up of medroxyprogesterone acetate therapy. Apropos of a case.] Rev Pneumol Clin 1995; 51: 284-287.
93. Zanella A, Toppan P, Nitti D, et al. Pulmonary lymphangioleiomyomatosis: a case report in postmenopausal woman treated with pleurodesis and progesterone (medroxyprogesterone acetate). Tumori 1996; 82: 96-98.
94. Wójcik P, Otto T, Jagiełło R, et al. Use of pleuro-peritoneal shunt in the treatment of chronic chylothorax. Pneumonol Alergol Pol 1998; 66: 473-479.
95. Calvo E, Amarillas L, Mateos MA, et al. Lymphangioleiomyomatosis, chylous ascites, and diet. Dig Dis Sci 1996; 41: 591-593.
96. Hamlin JA, Smith DC, Taylor FC, et al. Renal angiomyolipomas: long-term follow-up of embolization for acute hemorrhage. Can Assoc Radiol J 1997; 48: 191-198.
97. Williams JM, Racadio JM, Johnson ND, et al. Embolization of renal angiomyolipomata in patients with tuberous sclerosis complex. Am J Kidney Dis 2006; 47: 95-102.
98. Igarashi A, Masuyama T, Watanabe K, et al. Long-term result of the transcatheter arterial embolization for ruptured renal angiomyolipoma. Nippon Hinyokika Gakkai Zasshi 2002; 93: 702-706.
99. Bender B, Yunis E. The pathology of tuberous sclerosis. Pathol Annu 1982; 17: 339-382.
100. van Baal JG, Smits NJ, Keeman JN, et al. The evolution of renal angiomyolipomas in patients with tuberous sclerosis. J Urol 1994; 152: 35-38.
101. Yamakado K, Tanaka N, Nakagawa T, et al. Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture. Radiology 2002; 225: 78-82.
102. Trulock EP. Lung transplantation: special considerations and outcome in LAM. In: Moss J, ed. LAM and other Diseases Characterised by Smooth Muscle Proliferation. New York, Marcel Dekker, 1999; pp. 65-78.
103. Pigula FA, Griffith BP, Zenati MA, et al. Lung transplantation for respiratory failure resulting from systemic disease. Ann Thorac Surg 1997; 64: 1630-1634.
104. Kpodonu J, Massad MG, Chaer RA, et al. The US experience with lung transplantation for pulmonary lymphangioleiomyomatosis. J Heart Lung Transplant 2005; 24: 1247-1253.
105. Boehler A. Lung transplantation for cystic lung diseases: lymphangioleiomyomatosis, histiocytosis x, and sarcoidosis. Semin Respir Crit Care Med 2001; 22: 509-516.
106. Benden C, Rea F, Behr J, et al. Lung transplantation for lymphangioleiomyomatosis: the European experience. J Heart Lung Transplant 2009; 28: 1-7.
107. Reynaud-Gaubert M, Mornex JF, Mal H, et al. Lung transplantation for lymphangioleiomyomatosis: the French experience. Transplantation 2008; 86: 515-520.
108. Collins J, Muller NL, Kazerooni EA, et al. Lung transplantation for lymphangioleiomyomatosis: role of imaging in the assessment of complications related to the underlying disease. Radiology 1999; 210: 325-332.
109. Nine JS, Yousem SA, Paradis IL, et al. Lymphangioleiomyomatosis: recurrence after lung transplantation. J Heart Lung Transplant 1994; 13: 714-719.
110. Bittmann I, Rolf B, Amann G, et al. Recurrence of lymphangioleiomyomatosis after single lung transplantation: New insights into pathogenesis. Hum Pathol 2003; 34: 95-98.
111. Karbowniczek M, Astrinidis A, Balsara BR, et al. Recurrent lymphangiomyomatosis after transplantation: genetic analyses reveal a metastatic mechanism. Am J Respir Crit Care Med 2003; 167: 976-982.
112. Benden C, Boehler A, Faro A. Pediatric lung transplantation: Literature review. Pediatr Transplant 2008; 12: 266-273.